Company Analysis
Sign in

iBio, Inc. (IBIO)

Nasdaq: IBIO · Pharmaceutical Preparations · New York, NY · filing with the SEC since 2008
Full chart Alerts Compare
Grade3.4
◀ Past 2.1● Present 3.4▶ Future 4.0
1 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

23 patents granted to the 3 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to iBio, Inc.’s names, not what it holds today.

Patents granted
23
23 utility, 1976 to Dec 31, 2025
Granted in 2025
3
Against 1 in 2024 and 2 in 2023
Applications published
26
4 of them in 2025
Names they are printed under
3
its own name, a former name
By yearGrantedApplications published
'10'11'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Biotechnology3
Pharmaceuticals2
Computer technology1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name3 counted
iBio, Inc. its own name
US, as the owner printed on each patent. 2 more under the same name are not counted (printed in JP)
22 granted
5 published
iBio, Inc. its own name
named as the applicant on its applications, in US
0 granted
21 published
InB:Biotechnologies, Inc. a former name
US, as the owner printed on each patent
1 granted
0 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Nov 18, 202512,473,368CD25 antibodiesPharmaceuticalsiBio, Inc.
Oct 14, 202512,441,803Engineered CD25 polypeptides and uses thereofBiotechnologyiBio, Inc.
Feb 4, 202512,215,163CD25 antibodiesBiotechnologyiBio, Inc.
Oct 29, 202412,129,302Anti-CD-25 antibodyPharmaceuticalsiBio, Inc.
Jun 13, 202311,673,926In vivo de-glycosylation of recombinant proteins by co-expression with PNGase FBiotechnologyiBio, Inc.
Jan 3, 202311,545,238Machine learning method for protein modelling to design engineered peptidesComputer technologyiBio, Inc.
Nov 24, 202010,844,392Materials and methods for producing endostatin fusion polypeptides in plant cellsPharmaceuticalsiBio, Inc.
Nov 7, 20179,809,644Influenza hemagglutinin antibodies, compositions and related methodsBiotechnologyiBio, Inc.
Sep 19, 20179,765,349System for expression of genes in plantsBiotechnologyiBio, Inc.
Jan 24, 20179,551,001System for expression of genes in plantsBiotechnologyiBio, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Apr 17, 20252025/0122301CD25 ANTIBODIESBiotechnologyiBio, Inc.
Feb 27, 20252025/0066478HIGH-EFFICIENCY, CONDITIONALLY-ACTIVATED ANTIBODY DISCOVERY AND MASKED ANTIBODIESBiotechnologyiBio, Inc.
Jan 30, 20252025/0034267ANTI-CD-25 ANTIBODYPharmaceuticalsiBio, Inc.
Jan 16, 20252025/0019457TROP2 ANTIBODIESBiotechnologyiBio, Inc.
Oct 3, 20242024/0327515ANTI-CD3 ANTIBODIESBiotechnologyiBio, Inc.
Aug 8, 20242024/0262929ANTI-MUC16 ANTIBODIESBiotechnologyiBio, Inc.
Jul 11, 20242024/0228637CHEMOKINE RECEPTOR 8 (CCR8) ANTIBODIESPharmaceuticalsiBio, Inc.
Apr 25, 20242024/0132604CHEMOKINE RECEPTOR 8 (CCR8) ANTIBODIESPharmaceuticalsiBio, Inc.
Apr 11, 20242024/0117056EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III ANTIBODIESPharmaceuticalsiBio, Inc.
Mar 21, 20242024/0096443Generalized Scaffolds for Polypeptide Display and Uses ThereofComputer technologyiBio, Inc.
What it applied for, 2024 to 2025: Biotechnology 6 · Pharmaceuticals 4 · Computer technology 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton IBIO · research, not advice